Natixis

SEC CIK: 0001274981
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

ARCT holding history

Arcturus Therapeutics Holdings Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ARCT overview All 13F holders of ARCT Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of ARCT by Natixis, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−60−100.0%	Sold out	Holders
Q4 2025	60	$368	<0.1%	+60	New	Holders
Q2 2023	0	$0	0.0%	−11,500−100.0%	Sold out	Holders
Q1 2023	11,500	$275.7K	<0.1%	+11,500	New	Holders